Cognitive Processing Therapy vs. Sertraline for the Treatment of PTSD & SUD in Egyptian Patients
NCT ID: NCT03469128
Last Updated: 2021-04-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
150 participants
INTERVENTIONAL
2016-01-01
2020-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Processing Therapy for Syrian Patients With PTSD
NCT05031728
Comparison of Two Treatments for Post-Traumatic Stress Disorder
NCT00127673
Cognitive Processing Therapy in Syrian Women Exposed to IPV
NCT05674591
Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial
NCT01178671
Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress Disorder
NCT00391430
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive processing therapy
Cognitive Processing Therapy (CPT) in which participants completed 12 sessions of CPT
Cognitive processing therapy
Psychological treatment for patients suffering from PTSD and SUD symptoms.
Sertraline
Patients with co-occurrence PTSD \& SUD disorders were treated by Sertraline.
Sertraline
Sertraline for the treatment of post-traumatic stress and SU disorders
Control group
Placebo Control group
Placebo Control
Placebo Control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive processing therapy
Psychological treatment for patients suffering from PTSD and SUD symptoms.
Sertraline
Sertraline for the treatment of post-traumatic stress and SU disorders
Placebo Control
Placebo Control
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
British University In Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amani Safwat Albrazi
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amani Elbarazi, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
The British University in Egypt
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB Protocol CL-006
Identifier Type: REGISTRY
Identifier Source: secondary_id
2016-2017PTBUE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.